A genetic study of Wilson's disease in the United Kingdom

Brain

Volumn 136, Issue 5, 2013, Pages 1476-1487

  Coffey, Alison J ^a   Durkie, Miranda ^b   Hague, Stephen ^c   McLay, Kirsten ^a,d   Emmerson, Jennifer ^a   Lo, Christine ^c   Klaffke, Stefanie ^c   Joyce, Christopher J ^a   Dhawan, Anil ^e   Hadzic, Nedim ^e   Mieli Vergani, Giorgina ^e   Kirk, Richard ^b   Elizabeth Allen, K ^b   Nicholl, David ^f   Wong, Siew ^f   Griffiths, William ^g   Smithson, Sarah ^h   Giffin, Nicola ⁱ   Taha, Ali ^j   Connolly, Sally ^k   Gillett, Godfrey T ^l   Tanner, Stuart ^k   Bonham, Jim ^k   Sharrack, Basil ^c   Palotie, Aarno ^a,m,n   Rattray, Magnus ^c   Dalton, Ann ^b   Bandmann, Oliver ^c   more..

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b Sheffield Clinical Genetics Service   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d EARLHAM INSTITUTE   (United Kingdom)

^e KING S COLLEGE HOSPITAL   (United Kingdom)

^f CITY HOSPITAL   (United Kingdom)

^g ADDENBROOKE S HOSPITAL   (United Kingdom)

^h Department of Clinical Genetics ^*  (United Kingdom)

ⁱ ROYAL UNITED HOSPITALS BATH NHS FOUNDATION TRUST   (United Kingdom)

^j CROSSHOUSE HOSPITAL   (United Kingdom)

^k SHEFFIELD CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^l SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^m UNIVERSITY OF HELSINKI   (Finland)

ⁿ BROAD INSTITUTE OF MIT AND HARVARD   (United States)

more..

Author keywords

ATP7B; genetic prevalence; Wilson's disease

Indexed keywords

WILSON DISEASE PROTEIN;

ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MUTATION RATE; PATHOGENICITY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; UNIPARENTAL DISOMY; UNITED KINGDOM; WILSON DISEASE;

EID: 84877282333     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awt035     Document Type: Article

References (45)

1. Ala A, Borjigin J, Rochwarger A, Schilsky M. Wilson disease in septuagenarian siblings: Raising the bar for diagnosis. Hepatology 2005; 41: 668-70.
2. Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson's disease. Lancet 2007; 369: 397-408.
3. Bachmann H, Lossner J, Gruss B, Ruchholtz U. [The epidemiology of Wilson's disease in the German Democratic Republic and current problems from the viewpoint of population genetics]. Psychiatr Neurol Med Psychol (Leipz) 1979; 31: 393-400.
4. Beyersdorff A, Findeisen A. Morbus Wilson: Case report of a two-year-old child as first manifestation. Scand J Gastroenterol 2006; 41: 496-7.
5. Cullen LM, Prat L, Cox DW. Genetic variation in the promoter and 5' UTR of the copper transporter, ATP7B, in patients with Wilson disease. Clin Genet 2003; 64: 429-32.
6. Curtis D, Durkie M, Balac P, Sheard D, Goodeve A, Peake I, et al. A study of Wilson disease mutations in Britain. Hum Mutat 1999; 14: 304-11.
7. Czlonkowska A, Tarnacka B, Litwin T, Gajda J, Rodo M. Wilson's disease-cause of mortality in 164 patients during 1992-2003 observation period. J Neurol 2005; 252: 698-703.
8. Czlonkowska A, Rodo M, Gromadzka G. Late onset Wilson's disease: therapeutic implications. Mov Disord 2008; 23: 896-8.
9. Czlonkowska A, Gromadzka G, Chabik G. Monozygotic female twins discordant for phenotype of Wilson's disease. Mov Disord 2009; 24: 1066-9.
10. Dedoussis GV, Genschel J, Sialvera TE, Bochow B, Manolaki N, Manios Y, et al. Wilson disease: high prevalence in a mountainous area of Crete. Ann Hum Genet 2005; 69: 268-74.
11. Dziezyc K, Gromadzka G, Czlonkowska A. Wilson's disease in consecutive generations of one family. Parkinsonism Relat Disord 2011; 17: 577-8.
12. EASL. Clinical Practice Guidelines: Wilson's disease. J Hepatol 2012; 56: 671-85.
13. Ferenci P. Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing. Hum Genet 2006; 120: 151-9.
14. Firneisz G, Szonyi L, Ferenci P, Gorog D, Nemes B, Szalay F. Wilson disease in two consecutive generations: an exceptional family. Am J Gastroenterol 2001; 96: 2269-71.
15. Forbes JR, Cox DW. Functional characterization of missense mutations in ATP7B: Wilson disease mutation or normal variant? Am J Hum Genet 1998; 63: 1663-74.
16. Gojova L, Jansova E, Kulm M, Pouchla S, Kozak L. Genotyping microarray as a novel approach for the detection of ATP7B gene mutations in patients with Wilson disease. Clin Genet 2008; 73: 441-52.
17. Hahn SH, Lee SY, Jang YJ, Kim SN, Shin HC, Park SY, et al. Pilot study of mass screening for Wilson's disease in Korea. Mol Genet Metab 2002; 76: 133-6.
18. Kegley KM, Sellers MA, Ferber MJ, Johnson MW, Joelson DW, Shrestha R. Fulminant Wilson's disease requiring liver transplantation in one monozygotic twin despite identical genetic mutation. Am J Transplant 2010; 10: 1325-9.
19. Kenney SM, Cox DW. Sequence variation database for the Wilson disease copper transporter, ATP7B. Hum Mutat 2007; 28: 1171-7.
20. Lamont PJ, Davis MB, Wood NW. Identification and sizing of the GAA trinucleotide repeat expansion of Friedreich's ataxia in 56 patients. Clinical and genetic correlates. Brain 1997; 120 (Pt 4): 673-80.
21. Loudianos G, Dessi V, Lovicu M, Angius A, Figus A, Lilliu F, et al. Molecular characterization of wilson disease in the Sardinian population-evidence of a founder effect. Hum Mutat 1999; 14: 294-303.
22. Lovicu M, Dessi V, Lepori MB, Zappu A, Zancan L, Giacchino R, et al. The canine copper toxicosis gene MURR1 is not implicated in the pathogenesis of Wilson disease. J Gastroenterol 2006; 41: 582-7.
23. Mak CM, Lam CW, Tam S, Lai CL, Chan LY, Fan ST, et al. Mutational analysis of 65 Wilson disease patients in Hong Kong Chinese: identi-fication of 17 novel mutations and its genetic heterogeneity. J Hum Genet 2008; 53: 55-63.
24. Mihaylova V, Todorov T, Jelev H, Cherninkova S, Raycheva M, Savov A, et al. Wilson's disease in two consecutive generations in a Bulgarian Roma family. J Neurol 2007; 254: 1462-3.
25. Moller LB, Ott P, Lund C, Horn N. Homozygosity for a gross partial gene deletion of the C-terminal end of ATP7B in a Wilson patient with hepatic and no neurological manifestations. Am J Med Genet A 2005; 138: 340-3.
26. Nicastro E, Ranucci G, Vajro P, Vegnente A, Iorio R. Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease. Hepatology 2010; 52: 1948-56.
27. Ohura T, Abukawa D, Shiraishi H, Yamaguchi A, Arashima S, Hiyamuta S, et al. Pilot study of screening for Wilson disease using dried blood spots obtained from children seen at outpatient clinics. J Inherit Metab Dis 1999; 22: 74-80.
28. Olivarez L, Caggana M, Pass KA, Ferguson P, Brewer GJ. Estimate of the frequency of Wilson's disease in the US Caucasian population: a mutation analysis approach. Ann Hum Genet 2001; 65: 459-63.
29. Olsson C, Waldenstrom E, Westermark K, Landegre U, Syvanen AC. Determination of the frequencies of ten allelic variants of the Wilson disease gene (ATP7B), in pooled DNA samples. Eur J Hum Genet 2000; 8: 933-8.
30. Park HD, Park HK, Chung HS, Lee SY, Kim JW, Ki CS. Association of ATP7B mutation detection rate with biochemical characteristics in Korean patients with Wilson disease. Ann Clin Lab Sci 2010; 40: 15-9.
31. Park RH, McCabe P, Fell GS, Russell RI. Wilson's disease in Scotland. Gut 1991; 32: 1541-5.
32. Parkes D. Wilson's disease. Br Med J (Clin Res Ed) 1984; 288: 1180-1.
33. Reilly M, Daly L, Hutchinson M. An epidemiological study of Wilson's disease in the Republic of Ireland. J Neurol Neurosurg Psychiatry 1993; 56: 298-300.
34. Robinson WP. Mechanisms leading to uniparental disomy and their clinical consequences. Bioessays 2000; 22: 452-9.
35. Saito T. An assessment of efficiency in potential screening for Wilson's disease. J Epidemiol Community Health 1981; 35: 274-80.
36. Scheinberg IH. Penicillamine in Wilson's disease. Lancet 1982; 1: 1469.
37. Scheinberg IH, Sternlieb I. Wilson's disease. Philadelphia: WB Saunders; 1984.
38. Schmidt HH. Role of genotyping in Wilson's disease. J Hepatol 2009; 50: 449-52.
39. Seto WK, Mak CM, But D, Hung I, Lam CW, Tam S, et al. Mutational analysis for Wilson's disease. Lancet 2009; 374: 662.
40. Shah AB, Chernov I, Zhang HT, Ross BM, Das K, Lutsenko S, et al. Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. Am J Hum Genet 1997; 61: 317-28.
41. Sunyaev SR. Inferring causality and functional significance of human coding DNA variants. Hum Mol Genet 2012; 21: R10-7.
42. Taly AB, Meenakshi-Sundaram S, Sinha S, Swamy HS, Arunodaya GR. Wilson disease: description of 282 patients evaluated over 3 decades. Medicine (Baltimore) 2007; 86: 112-21.
43. Thomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW. The Wilson disease gene: spectrum of mutations and their consequences. Nat Genet 1995; 9: 210-7.
44. Tschumi A, Colombo JP, Moser H. Wilson's disease in Switzerland. Clinical, genetic and biochemical studies. Schweiz Med Wochenschr 1973; 103: 89-95.
45. Walshe JM. Cause Cause of death in Wilson disease. Mov Disord 2007; 22: 2216-20.